Related Experiment Video
Updated: Apr 7, 2026
03:05
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
1.7K
[Gastric ulcer, duodenal ulcer]
Nihon Rinsho. Japanese Journal of Clinical Medicine
|July 14, 2015
Summary
Peptic ulcer disease trends are shifting due to dietary changes and decreased Helicobacter pylori infections. Treatment focuses on endoscopic hemostasis for bleeding, with H. pylori eradication and proton pump inhibitors aiding healing and preventing recurrence.
Area of Science:
- Gastroenterology
- Internal Medicine
Context:
- Increasing acid secretion linked to Westernized diets and declining Helicobacter pylori (H. pylori) infection rates in Japan.
- Shifting trends in peptic ulcer disease (PUD), with a decrease in H. pylori-related ulcers and a rise in non-steroidal anti-inflammatory drug (NSAID)-induced ulcers.
Purpose:
- To outline current management strategies for upper gastrointestinal bleeding originating from peptic ulcers.
- To discuss the efficacy of H. pylori eradication and proton pump inhibitor (PPI) therapy in managing and preventing peptic ulcer recurrence.
Summary:
- Endoscopic hemostasis is the primary treatment for acute upper gastrointestinal bleeding from peptic ulcers.
- Surgical or interventional radiology (IVR) options are reserved for cases where endoscopic hemostasis is unsuccessful.
- H. pylori eradication therapy is crucial for healing and preventing recurrence of H. pylori-related ulcers, while PPI therapy is effective for preventing NSAID-induced ulcer recurrence.
Impact:
- Provides an overview of contemporary approaches to peptic ulcer disease management.
- Highlights the importance of targeted therapies based on ulcer etiology (H. pylori vs. NSAIDs).
- Informs clinical practice regarding the selection of appropriate treatments for upper gastrointestinal bleeding and ulcer recurrence prevention.
Related Concept Videos
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
820
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
820
01:30Peptic Ulcer Disease I: Introduction
1.1K
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
1.1K
01:27Peptic Ulcer
31
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the...
31
01:28Peptic Ulcer Disease II: Pathophysiology
2.8K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.8K
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
1.5K
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.5K
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
1.2K
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
1.2K